Sun, Apr 20, 2014, 2:54 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Dynavax Technologies Corporation Message Board

insttrader2 1 post  |  Last Activity: Jan 24, 2014 3:15 PM Member since: Dec 14, 2007
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • With the merger, which will undoubtedly go through, the number of shares outstanding is approximately 30 million. Unlike most biotech companies, the merged company actually has revenues, 17.5 million and about 7 million in cash. The Phase Ib results were very impressive and the market they are looking to serve is a billion dollar market. The P value demonstrates that the results were unlikely random. Of course the patient population was small and it was single site subject to investigator bias but the company will explain more about that on Monday after the close. Regardless, the data is extremely impressive and for this reason they holding a CC on Monday after the close. Just based on the P1b results the company should have a market cap of 100 million similar to peers or about 3.30 a share. Prior to the merger, ThermoGenesis was trading at it's lows around a dollar. Through the dollar on top of the 3.30 and you are at 4.30. This says nothing about the pipeline and the underlying business. Look for a run to 4 dollars next week.

1.500.00(0.00%)Apr 17 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.